| Health / Medical Topics |
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
A peptide cancer vaccine consisting of peptides derived from the melanoma antigen NA-17, the human leukocyte antigen HLA-A2-restricted human melanoma antigen 3 (MAGE-3.A2) and the cancer-testis antigen (NY-ESO-1), with potential immunostimulating and antineoplastic activities. Upon administration, the NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing NA-17, MAGE-3.A2 and NY-ESO-1, resulting in tumor cell lysis. The tumor-associated antigens (TAAs) NA-17, MAGE-3.A2 and NY-ESO-1 are overexpressed in a variety of cancer cell types. (NCI Thesaurus)
YOU MAY ALSO LIKE
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3c TNM…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3b TNM…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3a TNM…
Expressed in most nonlymphoid tissues including prostate, lung, liver, and colon by human N33 Gene (OST3 Family), 348-aa 40-kDa N33 Protein is…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding…
